Erythromelalgic Thrombotic Thrombocythemia (ETT) and Hemorrhagic Trombocythemia (HT) in Patients With Essential Thrombocythaemia (ET) and Polycythaemia Vera (PV)

Journal of Hematology & Thromboembolic Diseases
doi 10.4172/2329-8790.1000169
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Antiplatelet Drugs for Polycythaemia Vera and Essential Thrombocythaemia

Cochrane Database of Systematic Reviews
2013English

A Phase 2 Study of Simtuzumab in Patients With Primary, Post-Polycythaemia Vera or Post-Essential Thrombocythaemia Myelofibrosis

British Journal of Haematology
Hematology
2017English

Myocardial Infarction as a Thrombotic Complication of Essential Thrombocythemia and Polycythemia Vera

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2016English

Hydroxyurea (HU) Is Effective in Reducing JAK2V617F Mutated Clone Size in the Peripheral Blood of Essential Thrombocythemia (ET) and Polycythemia Vera (PV) Patients

Annals of Hematology
MedicineHematology
2008English

Updates in the Management of Polycythemia Vera and Essential Thrombocythemia

Therapeutic Advances in Hematology
Hematology
2019English

Hyperuricaemia in Polycythaemia Vera

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1966English

Survival of Polycythaemia Vera Patients Treated With Radioactive Phosphorus.

BMJ
1967English

ASXL1 Mutations in Chinese Patients With Essential Thrombocythemia

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Polycythemia Vera and Essential Thrombocythemia: 2019 Update on Diagnosis, Risk-Stratification and Management

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy